United Kingdom · Venture startup

Who invested in Ultromics

4 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$112Mraised across 4 rounds since 2018, from 4 sources

$13MSeries A$44MSeries B$55MSeries C
Latest round
VentureDec 2025
Biggest round
$55MSeries C · Jul 2025
Investors
12
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182019202020212022202320242025
$13MSeries A$44MSeries B$55MSeries C?Venture
First round
Series A, $13M
May 2018
Biggest round
$55M
Series C · Jul 2025
Usual gap between rounds
3.3 years
the median of 3

The rounds

  1. Dec 2025
    VentureAmount undisclosed1 new4 returning

    Source recorded

  2. Jul 2025
  3. Aug 2021
    Series B$44M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  4. May 2018
    Series A$13M7 new
    • Tanarra
    • Andre Crawford-Brunt
    • Dieter Spälti
    • Fushia
    • GT
    • Oxford Sciences Innovation/ Neptune
    • RT

    Reported by FinSMEs

Funding filed with regulators

Ultromics filed 6 raises, $86M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Nov 2025$3.9MUK share allotment
  2. Oct 2025$492KUK share allotment
  3. Sept 2025$1.5MUK share allotment
  4. Jul 2025$336KUK share allotment
  5. Jun 2025$35MUK share allotment
  6. Aug 2021$44MUK share allotment

Founders and team

From Ultromics's own website: 2 founders, 6 on the team.

Dr. Ross UptonFounder and Chief Executive Officer
Prof. Paul LeesonFounder and Chief Medical Officer
  • Amir HasanChief Operating Officer
  • Gary WoodwardChief Product Officer
  • Jaco JacobsChief Regulatory and Compliance Officer
  • Nancy SpagouChief Experience Officer
  • Roger OwensChief Commercial Officer
  • Dr. Helen RouthNon-Executive Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Series B2021Series C2025Venture2025Future Planet CapitalLightrockNina CapitalOptum VenturesGoogle VenturesTanarraAndre Crawford-BruntDieter SpältiFushiaGT

Everyone who backed them

Future Planet CapitalVC firm2rounds
LightrockVC firm2rounds
Nina CapitalVC firm2rounds
Optum VenturesVC firm2rounds
Google VenturesCorporate VC1round
TanarraInvestment firm1round
Andre Crawford-Bruntno record of our own yet1round
Dieter Spältino record of our own yet1round
Fushiano record of our own yet1round
GTno record of our own yet1round
Oxford Sciences Innovation/ Neptuneno record of our own yet1round
RTno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Ultromics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

NovaCapitalFamily officePer its own site

Quick answers about Ultromics

Who invested in Ultromics?

Ultromics's investors include Future Planet Capital, Lightrock, Nina Capital, Optum Ventures and Google Ventures, and 7 more on record.

How much has Ultromics raised?

Ultromics has raised $112M across 4 rounds since 2018. One round did not disclose an amount, so the total is a floor.

When did Ultromics last raise?

Ultromics's most recent round was a Venture in Dec 2025.

What was Ultromics's biggest round?

Ultromics's largest round on record is $55M (Series C), in Jul 2025.

Who backed Ultromics first?

Ultromics's first round on record, in May 2018, was backed by Tanarra, Andre Crawford-Brunt and Dieter Spälti and 4 others.

What stage is Ultromics at?

Ultromics's latest named round is a Venture, in Dec 2025.

Where is Ultromics based?

Ultromics is based in the United Kingdom.

Companies like Ultromics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.